Related references
Note: Only part of the references are listed.p53 Lesions in Leukemic Transformation
Ashot Harutyunyan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm
Philip A. Beer et al.
BLOOD (2010)
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Stephen T. Oh et al.
BLOOD (2010)
Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome-negative myeloproliferative neoplasms
Nils H. Thoennissen et al.
BLOOD (2010)
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations
Frank Stegelmann et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
A. Pardanani et al.
LEUKEMIA (2010)
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
R. Jaeger et al.
LEUKEMIA (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Somatic Mutations of IDH1 and IDH2 in the Leukemic Transformation of Myeloproliferative Neoplasms
Anthony Green et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms
Ye Ding et al.
BLOOD (2009)
AML transformation in 56 patients with Ph- MPD in two well defined populations
Khadija Abdulkarim et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis
Veronika Buxhofer-Ausch et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Conventional cytogenetics in myelofibrosis: literature review and discussion
Kebede Hussein et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post-Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
Constantine S. Tam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
UPD1p indicates the presence of MPL W515L mutation in RARS-T, a mechanism analogous to UPD9p and JAK2 V617F mutation
H. Szpurka et al.
LEUKEMIA (2009)
Mutations of ASXL1 gene in myeloproliferative neoplasms
N. Carbuccia et al.
LEUKEMIA (2009)
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
A. Tefferi et al.
LEUKEMIA (2009)
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
Masashi Sanada et al.
NATURE (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Whole genome scanning as a cytogenetic tool in hematologic malignancies
Jaroslaw P. Maciejewski et al.
BLOOD (2008)
JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders
Isabelle Plo et al.
BLOOD (2008)
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew J. Dunbar et al.
CANCER RESEARCH (2008)
Cytogenetic studies at diagnosis in polycythemia vera:: clinical and JAK2V617F allele burden correlates
Naseema Gangat et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
p110 CUX1 cooperates with E2F transcription factors in the transcriptional activation of cell cycle-regulated genes
Mary Truscott et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)
J. T. Reilly
LEUKEMIA (2008)
Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: Clinical implications
Anna D. Panani
CANCER LETTERS (2007)
Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia
Alessandro M. Vannucchi et al.
BLOOD (2007)
Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age
Derrick J. Rossi et al.
NATURE (2007)
Mechanisms of disease: The myeloproliferative disorders
Peter J. Campbell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients
Animesh D. Pardanani et al.
BLOOD (2006)
Inactivation of the p53 pathway in retinoblastoma
Nikia A. Laurie et al.
NATURE (2006)
Transgenic mice expressing the p75 CCAAT-displacement protein/cut homeobox isoform develop a myeloproliferative disease-like myeloid leukemia
Chantal Cadieux et al.
CANCER RESEARCH (2006)
Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders
Robert Kralovics et al.
BLOOD (2006)
Foxp1 is an essential transcriptional regulator of B cell development
Hui Hu et al.
NATURE IMMUNOLOGY (2006)
ETV6: A versatile player in leukemogenesis
SK Bohlander
SEMINARS IN CANCER BIOLOGY (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
RL Levine et al.
CANCER CELL (2005)
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
EJ Baxter et al.
LANCET (2005)
Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target
MJ Riemenschneider et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Detection of FLT3 internal tandem duplication and D835 mutations by a multiplex polymerase chain reaction and capillary electrophoresis assay
KM Murphy et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera
R Kralovics et al.
EXPERIMENTAL HEMATOLOGY (2002)
Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping
MD Odero et al.
GENES CHROMOSOMES & CANCER (2001)